Putting women in the centre of the global HIV response is key to achieving epidemic control!

Quarraisha Abdool Karim^#^{1

2}, Diane Havlir^#³, Nittaya Phanuphak^#⁴

Affiliations

¹ Centre for the AIDS Programme of Research in South Africa, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
² Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
³ Department of Medicine, University of California, San Francisco, CA, USA.
⁴ PREVENTION, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.

^# Contributed equally.

Review

Quarraisha Abdool Karim et al. J Int AIDS Soc. 2020 Mar.

. 2020 Mar;23(3):e25473.

doi: 10.1002/jia2.25473.

Quarraisha Abdool Karim^#^{1

2}, Diane Havlir^#³, Nittaya Phanuphak^#⁴

¹ Centre for the AIDS Programme of Research in South Africa, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
² Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
³ Department of Medicine, University of California, San Francisco, CA, USA.
⁴ PREVENTION, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.

^# Contributed equally.

No abstract available

Keywords: HIV; ageing; prevention; transgender women; treatment; women.

References

1. UNAIDS . Miles to go: closing gaps, breaking barriers, righting injustices. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2018.
1. de Oliveira T, Kharsany AB, Graf T, Cawood C, Khanyile D, Grobler A, et al. Transmission networks and risk of HIV infection in KwaZulu‐Natal, South Africa: a community‐wide phylogenetic study. Lancet HIV. 2017;4(1):e41–50. - PMC - PubMed
1. McKinnon LR, Liebenberg LJ, Yende‐Zuma N, Archary D, Ngcapu S, Sivro A, et al. Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. Nat Med. 2018;24(4):491–6. - PMC - PubMed
1. Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, et al. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015;61(2):260–9. - PMC - PubMed
1. Klatt NR, Cheu R, Birse K, Zevin AS, Perner M, Noel‐Romas L, et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 2017;356(6341):938–45. - PubMed